Taros Chemicals
Private Company
Funding information not available
Overview
Taros Chemicals is a well-established, privately-held chemistry CRO based in Dortmund, Germany, with over two decades of operational history. The company operates a customer-centric, service-based business model, leveraging a team of highly qualified chemists to execute custom synthesis and research projects for a diverse global clientele. With a track record of over 13,000 projects, Taros supports innovation across drug discovery, performance chemicals, and material science, offering a flexible and integrated approach to R&D challenges. Its financial position is supported by project revenue and public funding, positioning it as a specialized partner in the outsourced chemistry services market.
Technology Platform
Integrated discovery chemistry services specializing in organic/organometallic synthesis, custom compound design, and scale-up from lab to pilot scale. Core asset is a team of expert chemists (65% Ph.D.) providing end-to-end contract research.
Opportunities
Risk Factors
Competitive Landscape
Taros competes in the fragmented chemistry CRO market against large global players (e.g., Evotec, WuXi AppTec), mid-sized specialized CROs, and academic spin-offs. Its differentiation lies in its deep synthetic expertise, flexible business model, and focus on providing full IP ownership to clients. Its European base and industrial chemistry capabilities offer a broader value proposition than pure-play medicinal chemistry CROs.